Provided by Tiger Trade Technology Pte. Ltd.

Summit Therapeutics PLC

16.76
+0.06500.39%
Post-market: 16.820.0611+0.36%19:59 EDT
Volume:5.20M
Turnover:87.53M
Market Cap:13.37B
PE:-14.99
High:17.32
Open:16.96
Low:16.66
Close:16.69
52wk High:29.23
52wk Low:12.07
Shares:797.75M
Float Shares:152.34M
Volume Ratio:0.45
T/O Rate:3.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1177
EPS(LYR):-1.4439
ROE:-192.50%
ROA:-101.61%
PB:21.22
PE(LYR):-11.60

Loading ...

Sector Update: Healthcare

MT Newswires Live
·
8 hours ago

Deals of the Day-Mergers and Acquisitions

Reuters
·
Yesterday

Summit Therapeutics enters trial collaboration with AstraZeneca, Daiichi Sankyo

TIPRANKS
·
Yesterday

Major Drugmakers Turn to China for Licensing Deals

Reuters
·
Yesterday

AstraZeneca & Daiichi Sankyo Announce Clinical Collaboration with Summit Therapeutics

Reuters
·
Yesterday

Summit Therapeutics Partners with AstraZeneca, Daiichi Sankyo to Test Ivonescimab with Datroway in Solid Tumors

Reuters
·
Yesterday

AstraZeneca - Co, Daiichi Sankyo, Summit to Contribute to Trial Costs and Retain Rights

THOMSON REUTERS
·
Yesterday

Summit Therapeutics Announces Clinical Trial Collaboration with AstraZeneca and Daiichi Sankyo to Evaluate Ivonescimab in Combination with Trop2-Directed ADC Datroway

THOMSON REUTERS
·
Yesterday

Summit Therapeutics is Maintained at Equal-Weight by Barclays

Dow Jones
·
Oct 01

Summit Therapeutics Inc. : Barclays Raises Target Price to $20 from $18

THOMSON REUTERS
·
Oct 01

Analysts Offer Insights on Healthcare Companies: AbSci (ABSI), Summit Therapeutics (SMMT) and Sutro Biopharma (STRO)

TIPRANKS
·
Oct 01

Movement Alert|Summit Therapeutics PLC Rises 5.03% in Regular Trading, AstraZeneca $2 Billion Investment Continues to Boost Sentiment

Market Focus
·
Sep 30

Major Drugmakers Turn to China for Licensing Deals

Reuters
·
Sep 30

AstraZeneca Hedges Threat to Oncology Portfolio

Dow Jones
·
Sep 30

UK Car Production Rises 5.7% in August

Deep News
·
Sep 30

FTSE 100 Hits Two-Week Low as Energy Stocks Slide

Reuters
·
Sep 30

Unusually active option classes on open September 29th

TIPRANKS
·
Sep 29

Movement Alert|Summit Therapeutics PLC Rises 18.98% in Regular Trading, AstraZeneca Invests $2 Billion to Deepen Ivonescimab Collaboration

Market Focus
·
Sep 29

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Sep 29

Leerink Partners Sticks to Its Hold Rating for Summit Therapeutics (SMMT)

TIPRANKS
·
Sep 29